Exchange: NASDAQ·Updated 07:30 PM EST

YARW Yarrow Bioscience Inc.

$15.48
$0.31
(1.96%)
Today
Closed $15.48
$0.00
(0.00%)
After Hours
Mkt Cap$149.02M
Vol92,026.00

About YARW

Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.
69

Bullish Sentiment

How do you feel about YARW?

Advertisement|Remove ads.